Stellar Biotechnologies Inc (SBOT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Stellar Biotechnologies Inc (SBOT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7891
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injectable product to assess immune response. Its products comprise Stellar KLH protein which can be used in various grades, formulations, and configurations for both clinical and research applications and KLH Elisa Kits. Stellar Bio’s products are used in immunotherapies as an immune stimulant in immunotoxicology applications and therapeutic vaccine conjugation. The company partners with research centers and developers of active immunotherapies and therapeutic vaccines. Stellar Bio is headquartered in Port Hueneme, California, the US.

Stellar Biotechnologies Inc (SBOT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stellar Biotechnologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stellar Biotechnologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stellar Biotechnologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stellar Biotechnologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Stellar Biotechnologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stellar Biotechnologies Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Stellar Biotech to Raise USD3 Million in Private Placement of Shares up on Exercise of Warrants 10
Stellar Biotech Raises USD5.5 Million in Public Offering of Units 11
Stellar Biotechnologies Completes Second Tranche Private Placement Of Units For US$12 Million 12
Stellar Biotechnologies Completes Second Tranche Of Private Placement Of Units For US$5 Million 14
Stellar Biotechnologies Completes Private Placement Of Units For US$1.6 Million 16
Stellar Biotechnologies Inc – Key Competitors 17
Stellar Biotechnologies Inc – Key Employees 18
Stellar Biotechnologies Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Recent Developments 20
Financial Announcements 20
Aug 08, 2018: Stellar Biotechnologies reports third quarter financial results 20
May 07, 2018: Stellar Biotechnologies Announces Second Quarter Financial Results 22
Feb 07, 2018: Stellar Biotechnologies Reports First Quarter 2018 Financial Results 24
Dec 01, 2017: Stellar Biotechnologies Reports Fiscal Year 2017 Financial Results 25
May 09, 2017: Stellar Biotechnologies Reports Second Quarter 2017 Financial Results 26
Feb 06, 2017: Stellar Biotechnologies Reports First Quarter 2017 Financial Results 28
Corporate Communications 29
Feb 27, 2018: Stellar Biotechnologies Appoints Bioprocess Expert to Lead Manufacturing 29
Jan 25, 2018: Stellar Biotechnologies Appoints Pharma Licensing Expert to Board of Directors 30
Jun 07, 2017: Stellar Biotechnologies Expands Operations Team 31
Other Significant Developments 32
Mar 06, 2017: The Life Sciences Report Examines Stellar Biotechnologies Inking Multiyear KLH Supply Agreement with Amaran Biotechnology; Stellar Up 27% on News 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Stellar Biotechnologies Inc, Medical Equipment, Key Facts, 2017 2
Stellar Biotechnologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Stellar Biotechnologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stellar Biotechnologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stellar Biotechnologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stellar Biotechnologies Inc, Deals By Market, 2012 to YTD 2018 8
Stellar Biotechnologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stellar Biotech to Raise USD3 Million in Private Placement of Shares up on Exercise of Warrants 10
Stellar Biotech Raises USD5.5 Million in Public Offering of Units 11
Stellar Biotechnologies Completes Second Tranche Private Placement Of Units For US$12 Million 12
Stellar Biotechnologies Completes Second Tranche Of Private Placement Of Units For US$5 Million 14
Stellar Biotechnologies Completes Private Placement Of Units For US$1.6 Million 16
Stellar Biotechnologies Inc, Key Competitors 17
Stellar Biotechnologies Inc, Key Employees 18
Stellar Biotechnologies Inc, Subsidiaries 19
Stellar Biotechnologies Inc, Joint Venture 19

List of Figures
Stellar Biotechnologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Stellar Biotechnologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Stellar Biotechnologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Stellar Biotechnologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Stellar Biotechnologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stellar Biotechnologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Stellar Biotechnologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stellar Biotechnologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Stellar Biotechnologies Inc (SBOT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Precision Drilling Corporation (PD):石油・ガス:M&Aディール及び事業提携情報
    Summary Precision Drilling Corp (Precision) is a provider of onshore drilling and production services to exploration and production companies in the oil and natural gas industry. It offers contract drilling, well servicing and other support services to oil and natural gas exploration and production …
  • Strongbridge Biopharma plc (SBBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Strongbridge Biopharma Plc (Strongbridge Biopharma), formerly Cortendo Plc is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product KEVEYIS (dichlorphenamide) is indicated for the treatment of hypokalemic, hy …
  • Merus NV (MRUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Merus NV (Merus) is a clinical-stage immuno-oncology company that discovers and develops human bispecific antibody therapeutics for the treatment of cancer. The company’s pipeline antibody candidates are intended for the treatment of breast cancer, ovarian cancer, colorectal cancer, acute my …
  • Tohoku Electric Power Co Inc:発電所・企業SWOT分析
    Tohoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析
    Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Corindus Vascular Robotics Inc (CVRS):企業の財務・戦略的SWOT分析
    Summary Corindus Vascular Robotics Inc (Corindus) is a medical device company that designs, manufactures and commercializes remote robotic systems for interventional surgical procedures. The company offers next-generation CorPath GRX system, a robotic platform that enables improvements in procedural …
  • China Meheco Co Ltd:企業の戦略・SWOT・財務情報
    China Meheco Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Meheco Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • LifeTech Scientific Corporation (1302):医療機器:M&Aディール及び事業提携情報
    Summary LifeTech Scientific Corporation (LifeTech Scientific) is a manufacturer, suppler and marketer of interventional medical devices for cardiovascular diseases. The product portfolio of the company includes occluders, stent graft system, delivery system, vena cava fitter, vascular plug, sizzing …
  • Pirelli & C. S.p.A.:企業の戦略・SWOT・財務情報
    Pirelli & C. S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Pirelli & C. S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Volta River Authority:企業の戦略的SWOT分析
    Volta River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hotel Grand Central Limited:企業の戦略・SWOT・財務情報
    Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Molex LLC-医療機器分野:企業M&A・提携分析
    Summary Molex LLC (Molex), a subsidiary of Koch Industries, is a US-based manufacturer of electronic components. The company principally focuses on manufacturing and sale of electronic, electrical and fiber optic interconnection systems. Molex's product portfolio includes switches, integrated produc …
  • Orly International, Inc.:企業の戦略・SWOT・財務情報
    Orly International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Orly International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Southern Maryland Electric Cooperative Inc:発電所・企業SWOT分析
    Southern Maryland Electric Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, infor …
  • Sumatec Resources Bhd (SUMATEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Sumatec Resources Bhd (Sumatec) is an oilfield service provider that offers of construction and drilling services to the oil and gas industry. The company’s services include engineering and construction for oil and gas facilities, oil and gas assets development, supply and management of onsh …
  • United Utilities Group Plc (UU):電力:M&Aディール及び事業提携情報
    Summary United Utilities Group PLC (United Utilities) is a provider of water and wastewater services. It gathers water from reservoirs, lakes, boreholes and streams; and collects and treats wastewater, and deposits it into rivers and sea. The company extracts water from Lake Vyrnwy in Wales for cust …
  • Belfius Bank Sa:企業の戦略・SWOT・財務分析
    Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tyson Fresh Meats Inc:戦略・SWOT・企業財務分析
    Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CytoDel Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CytoDel Inc (CytoDel) is a biopharmaceutical company that utilizes molecular biology tools to produce recombinant derivatives of botulinum neurotoxin (BoNT). The company provides product portfolio such as Ctyo-111, an antidote to botulism; and Cyto-012 a recombinant BoNT derivative, among ot …
  • Marmen Inc:企業の戦略的SWOT分析
    Marmen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆